Wilmington, DE -- (SBWIRE) -- 08/19/2013 -- Equity Profile Report expands its NASDAQ Active Stock Weekly Watch List adding Gilead Sciences Inc. (NASDAQ:GILD) and JDS Uniphase Corporation (NASDAQ:JDSU).
Gilead Sciences Inc. (NASDAQ:GILD) a biopharmaceutical company that discovers, develops, and commercializes human therapeutics for the treatment of life threatening diseases in North America, Europe, and Asia is currently up (+0.68%) on 4,463,271 shares traded. Gilead Sciences Inc. (NASDAQ:GILD) is currently up (+108.09%) from its recent 52-week low which has prompted Equity Profile Report to add the stock to their NASDAQ Active Stock Watch List.
Click Here to find out what other Investors are saying about Gilead Sciences Inc. (NASDAQ:GILD)
JDS Uniphase Corporation (NASDAQ:JDSU) a company that provides communications test and measurement solutions, and optical products for telecommunications service providers, wireless operators, cable operators, network-equipment manufacturers, and enterprises worldwide is currently down (-1.90%) on 4,035,148 shares traded after JDS UNIPHASE CORP /CA/ Filed SEC form 8-K, Termination of a Material Definitive Agreement, Other Events, Financial Statements and Exhibits. JDS Uniphase Corporation (NASDAQ:JDSU) is currently down (-13.37%) from its recent 52-week high which has prompted Equity Profile Report to add the stock to their NASDAQ Active Stock Watch List.
Click Here to find out what other Investors are saying about JDS Uniphase Corporation (NASDAQ:JDSU)
Equityprofilereport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.
Through a vast network of IR professionals Equityprofilereport.com is often aware of several large investor awareness campaigns being deployed.
Timing is important when trading Small Caps and Penny Stocks.
Simply sign up for free and start receiving exclusive alerts.
Subscribe Here: http://www.Equityprofilereport.com
Disclosure: Equityprofilereport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit Equityprofilereport.com website, for complete risks and disclosures.
Equity Profile Report
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)